Home » Topics » Regulatory » Patents

Patents
RSS

New agents for cytokine- and/or CAM-mediated disorders disclosed by Pfizer

Oct. 7, 1998

Synthesis and activity of new antifungal agents reported by Nihon Nohyaku

Oct. 7, 1998

Wakamoto discovers natural substances for Alzheimer's disease

Oct. 7, 1998

Dopamine reuptake inhibitors synthesized at Pola, useful for Parkinson's disease

Oct. 6, 1998

Ono discloses compounds with high binding affinity for prostanoid EP4 receptors

Oct. 6, 1998

Basic research in the field of vitronectin antagonists revealed by HMR

Oct. 6, 1998

Tanabe presents new antidiabetic agents

Oct. 6, 1998

Antitumor agents with high potency and selectivity under evaluation at Shionogi

Oct. 6, 1998

Banyu patents new series of NPY antagonists for obesity, bulimia, diabetes

Oct. 6, 1998

BASF describes novel inhibitors of cysteine proteases

Oct. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...